# Study to Understand Novel Biomarkers in Researching Dementia

> **NCT06547099** · — · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 1800 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Dementia

## Interventions

- **DIAGNOSTIC_TEST:** Clinical tau PET
- **DIAGNOSTIC_TEST:** Clinical amyloid test
- **OTHER:** Research blood collection
- **OTHER:** Cognitive assessments

## Key facts

- **NCT ID:** NCT06547099
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-14
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06547099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06547099, "Study to Understand Novel Biomarkers in Researching Dementia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06547099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*